Cargando…
SLC26A9 as a Potential Modifier and Therapeutic Target in Cystic Fibrosis Lung Disease
SLC26A9 belongs to the solute carrier family 26 (SLC26), which comprises membrane proteins involved in ion transport mechanisms. On the basis of different preliminary findings, including the phenotype of SlC26A9-deficient mice and its possible role as a gene modifier of the human phenotype and treat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961553/ https://www.ncbi.nlm.nih.gov/pubmed/35204703 http://dx.doi.org/10.3390/biom12020202 |